Key Financials Snapshot

TTM · Standalone · ₹ in Cr
Market Cap
₹599 Cr.
Stock P/E
28.9
P/B
0.3
Current Price
₹86.2
Book Value
₹ 330.8
Face Value
2
52W High
₹160.5
52W Low
₹ 85.1
Dividend Yield
4.06%

Uniphos Enterprises Overview

Business

Uniphos Enterprises Ltd. is an India-based company primarily engaged in trading activities. While the specific nature of goods traded can vary, historical information indicates a focus on trading of various chemicals, including intermediates, and agricultural products. The company acts as an intermediary, procuring goods from manufacturers/suppliers and distributing them to end-users or other businesses, thereby earning a margin on the traded volume. Its core business model involves managing logistics, supply chain, and financing to facilitate transactions.

Revenue Mix

Uniphos Enterprises Ltd. primarily operates as a single business segment, "Trading." Publicly available financial reports generally do not break down revenue by distinct product categories within its trading operations, indicating a largely unified trading business without significant, separately reported segments.

Industry

The trading industry in India is highly fragmented and competitive, comprising a wide range of players from small local traders to large multinational trading houses. Uniphos Enterprises Ltd. operates within this general trading landscape, likely focusing on specific niches within chemicals and agri-products where it has established supplier relationships and distribution networks. Its positioning is that of an established, mid-sized player in specific commodity trading segments rather than a broad-line global trading giant.

MOAT

Uniphos Enterprises Ltd. generally operates in a low-moat business. Its potential competitive advantages are primarily operational:

Established Relationships: Long-standing relationships with suppliers and customers can provide a degree of stability and preferential terms.

Logistics & Supply Chain Expertise: Efficient management of procurement, warehousing, and distribution in specific product categories.

Financing Capabilities: Ability to provide credit terms to buyers or manage working capital efficiently for large trade volumes.

However, these advantages are typically not strong enough to create a durable, wide moat as they can often be replicated by competitors.

Growth Drivers

Economic Growth: Overall economic growth in India drives demand for chemicals and agricultural products, which are key items for the company's trading.

Expansion into New Products/Geographies: Strategic initiatives to add new product lines or expand trading operations into new regions could provide growth avenues.

Supply Chain Optimization: Improving efficiency in logistics and inventory management could enhance profitability per unit traded.

Commodity Price Volatility: While a risk, strategic hedging and timely trading during price fluctuations can also be a source of profit.

Risks

Commodity Price Volatility: Fluctuations in the prices of traded goods can significantly impact margins and inventory valuations.

Foreign Exchange Risk: If the company engages in international trade, currency fluctuations can affect profitability.

Credit Risk: Risk of default by counterparties to whom goods are sold on credit.

Supply Chain Disruptions: Issues with sourcing, logistics, or transportation can hinder operations.

Intense Competition: The fragmented nature of the trading industry means constant pressure on margins.

Regulatory Changes: Changes in import/export policies, tariffs, or other trade regulations can impact the business.

Management & Ownership

Uniphos Enterprises Ltd. is part of the broader UPL Group, with the Shroff family (promoters of UPL Ltd.) being the key promoters. Promoters hold a significant stake, which is common in Indian businesses and can align management interests with shareholders. While specific details on the day-to-day management quality would require deeper analysis, the association with the UPL Group suggests a lineage of business acumen in the chemical and agri-products space.

Outlook

Uniphos Enterprises Ltd. operates in a fundamental but competitive trading sector. The company's outlook is closely tied to the broader economic environment and the performance of the specific chemical and agricultural markets it serves. The bull case relies on sustained economic growth in India, effective management of commodity price risks, and leveraging its established relationships and supply chain expertise to capture market share and optimize margins. The bear case involves heightened competition leading to margin erosion, adverse movements in commodity prices, significant supply chain disruptions, or credit defaults from counterparties. While the company's established presence provides a base, significant growth would likely require strategic expansion or diversification within its trading framework.

Uniphos Enterprises Share Price

Live · BSE / NSE · Inception: 1969
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Standalone · annual

Uniphos Enterprises Quarterly Results

#(Fig in Cr.) Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 51 3 30 5 73 6 0 0 26 0
Other Income 1 1 5 0 0 0 24 0 0 0
Total Income 51 4 35 6 73 6 24 0 27 0
Total Expenditure 52 4 31 6 74 7 1 1 27 1
Operating Profit -0 0 4 -1 -1 -1 23 -1 -0 -1
Interest 0 0 0 1 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax -0 -0 4 -2 -2 -1 23 -1 -1 -1
Provision for Tax 0 0 0 -0 0 0 0 0 0 0
Profit After Tax -1 -0 4 -2 -2 -1 23 -1 -1 -1
Adjustments -0 0 0 0 0 0 0 0 0 -0
Profit After Adjustments -1 -0 4 -2 -2 -1 23 -1 -1 -1
Adjusted Earnings Per Share -0.1 -0 0.6 -0.3 -0.2 -0.1 3.3 -0.1 -0.1 -0.2

Uniphos Enterprises Profit & Loss

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Net Sales 0 0 0 0 0 1 1 1 51 112 32 26
Other Income 14 13 20 24 23 26 57 43 43 6 25 24
Total Income 14 13 20 24 24 27 58 45 94 118 57 51
Total Expenditure 1 2 2 3 3 4 4 4 54 115 36 30
Operating Profit 12 11 18 21 20 23 54 40 40 2 22 21
Interest 0 0 0 0 0 0 0 0 0 1 0 0
Depreciation 0 0 0 0 0 0 0 1 1 1 1 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 12 11 18 21 20 23 54 40 39 0 21 20
Provision for Tax -0 0 0 0 0 -1 -1 0 0 -0 0 0
Profit After Tax 12 11 18 21 20 24 55 39 39 0 21 20
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 12 11 18 21 20 24 55 39 39 0 21 20
Adjusted Earnings Per Share 1.7 1.6 2.5 3 2.9 3.5 7.9 5.6 5.6 0 3 2.9

Uniphos Enterprises Balance Sheet

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Shareholder's Funds 283 2067 2090 2698 1518 2715 3181 2998 2075 2742 2447
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 0 0 57 120 97 -21 98 144
Total Current Liabilities 0 0 0 0 1 0 1 1 2 2 28
Total Liabilities 284 2067 2090 2698 1519 2772 3302 3095 2056 2842 2619
Fixed Assets 174 175 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 107 1878 2059 2659 1459 2711 3242 3042 2008 2825 2572
Total Current Assets 3 14 31 38 59 61 60 53 48 16 47
Total Assets 284 2067 2090 2698 1519 2772 3302 3095 2056 2842 2619

Uniphos Enterprises Cash Flow

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Opening Cash & Cash Equivalents 2 2 1 6 1 43 4 2 1 3 12
Cash Flow from Operating Activities -2 -2 -3 -3 -2 -5 1 -1 -3 -3 -3
Cash Flow from Investing Activities 14 -0 9 -2 44 -34 20 41 50 53 10
Cash Flow from Financing Activities -11 0 0 0 0 0 -24 -39 -45 -41 -3
Net Cash Inflow / Outflow 1 -2 5 -5 42 -38 -3 -0 1 9 3
Closing Cash & Cash Equivalent 2 1 6 1 43 4 2 1 3 12 15

Uniphos Enterprises Ratios

# Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Earnings Per Share (Rs) 1.7 1.62 2.54 2.99 2.89 3.52 7.85 5.64 5.55 0.04 2.98
CEPS(Rs) 1.7 1.63 2.55 2.99 2.89 3.52 7.86 5.73 5.67 0.15 3.08
DPS(Rs) 0 0 0 0 0 3.4 5.65 6.5 5.7 0.5 3.5
Book NAV/Share(Rs) 19.91 276.32 279.65 367.04 197.4 369.5 436.48 410.17 277.58 373.37 330.97
Core EBITDA Margin(%) 0 0 0 0 -1302.78 -368.01 -255.85 -194.48 -6.1 -3.43 -11.62
EBIT Margin(%) 0 0 0 0 9006.61 2809.85 4414.68 2691.85 76.89 1.38 65.07
Pre Tax Margin(%) 0 0 0 0 9006.61 2809.85 4414.68 2691.85 76.89 0.2 65.07
PAT Margin (%) 0 0 0 0 8851.15 2936.36 4469.12 2664.95 76.24 0.25 64.72
Cash Profit Margin (%) 0 0 0 0 8867.2 2940.51 4471.8 2705.89 77.88 0.93 66.85
ROA(%) 4.17 0.96 0.85 0.87 0.95 1.14 1.8 1.23 1.5 0.01 0.76
ROE(%) 8.9 1.09 0.91 0.92 1.02 1.24 1.95 1.33 1.61 0.01 0.85
ROCE(%) 8.85 1.09 0.93 0.94 1.04 1.19 1.92 1.35 1.63 0.07 0.85
Receivable days 0 0 0 0 0 0 0 0 3.49 0 298.19
Inventory Days 0 0 0 0 0 0 0 0 0 0 0
Payable days 0 0 0 0 684.19 189.2 90.49 143.3 7.95 3.66 159.17
PER(x) 19.84 44.15 32.48 37.36 13.62 24.15 16.86 27.29 24.13 3897.5 30.94
Price/Book(x) 1.69 0.26 0.3 0.3 0.2 0.23 0.3 0.38 0.48 0.42 0.28
Dividend Yield(%) 0 0 0 0 0 4 4.27 4.22 4.26 0.32 3.8
EV/Net Sales(x) 0 0 0 0 1016.53 703.89 747.83 705.43 17.46 9.58 19.53
EV/Core EBITDA(x) 18.91 43.9 31.42 36.49 11.27 25.01 16.93 25.81 22.23 464.68 29.06
Net Sales Growth(%) -100 0 0 0 0 267.15 46.73 20.47 3340.99 120.17 -71.3
EBIT Growth(%) 26.04 -7.51 60.16 17.44 -3.58 14.54 130.53 -26.54 -1.71 -96.04 1248.79
PAT Growth(%) 38.4 -4.52 57.05 17.39 -3.32 21.8 123.32 -28.16 -1.56 -99.28 7341.93
EPS Growth(%) 38.4 -4.51 57.05 17.39 -3.32 21.8 123.32 -28.16 -1.56 -99.28 7345
Debt/Equity(x) 0 0 0 0 0 0 0 0 0 0 0
Current Ratio(x) 13.88 91.19 189.65 219.18 83.41 229.58 100.1 50.39 23.44 8.83 1.68
Quick Ratio(x) 13.88 91.19 189.65 219.18 83.41 229.58 100.1 50.39 23.44 8.83 1.68
Interest Cover(x) 31.87 0 0 0 0 0 0 0 0 1.17 0
Total Debt/Mcap(x) 0 0 0 0 0 0 0 0 0 0 0

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -71% +217% +100% —
Operating Profit CAGR +1000% -18% -1% +6%
PAT CAGR — -19% -3% +6%
Share Price CAGR -42% -18% -7% +2%
ROE Average +1% +1% +1% +2%
ROCE Average +1% +1% +1% +2%

Uniphos Enterprises Shareholding Pattern

Latest · Sep 2026
100% held
Promoters 73.79 %
FII 15.82 %
DII (MF + Insurance) 0.01 %
Public (retail) 10.39 %
# Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Promoter 73.7973.7973.7973.7973.7973.7973.7973.7973.7973.79
FII 15.7115.7215.7115.7115.7115.7115.7115.8215.8215.82
DII 0.010.010.010.010.010.010.010.010.010.01
Public 10.4910.4910.4910.4910.510.510.510.3910.3910.39
Others 0000000000
Total 100100100100100100100100100100

Uniphos Enterprises Peer Comparison

Uniphos Enterprises Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Uniphos Enterprises Pros & Cons

Pros

  • Stock is trading at 0.3 times its book value
  • Company is almost debt free.

Cons

  • Company has a low return on equity of 1% over the last 3 years.
  • Debtor days have increased from 3.66 to 159.17days.
  • Earnings include an other income of Rs. 25 Cr.
  • The company has delivered a poor profit growth of -2% over past five years.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp